Skip to main content
Changmao Biochemical Engineering Company Limited logo

Changmao Biochemical Engineering Company Limited — Investor Relations & Filings

Ticker · 954 ISIN · CNE1000002Q0 HKEX Manufacturing
Open in API
Filings indexed 440 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 954

About Changmao Biochemical Engineering Company Limited

http://www.cmbec.com.hk

Changmao Biochemical Engineering Company Limited is a specialized producer of organic acids and their derivatives, focusing primarily on the four-carbon series. Key products include L-malic acid, DL-malic acid, L(+)-tartaric acid, DL-tartaric acid, and fumaric acid. These organic acids, often derived from maleic anhydride, serve critical functions across diverse markets, including food ingredients, pharmaceuticals, chemical manufacturing, and new materials development. Established in 1992, the company has historically been noted as China's first malic acid supplier and maintains a focus on advanced technology, operating research centers dedicated to biochemical chiral engineering.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report concerning movements in securities, specifically focusing on authorized and issued share capital, treasury shares, public float sufficiency, and confirmations related to compliance with listing rules. It is addressed to the Hong Kong Exchanges and Clearing Limited and references specific listing rules (e.g., Main Board Rule 13.32D, GEM Rule 17.37D). The document includes no financial statements or earnings data but provides regulatory compliance information about share capital and share movements for the month ended 30 April 2026. It is a regulatory submission related to share capital and shareholding movements rather than a financial report, earnings release, or management discussion. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2026-05-04 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of the Annual General Meeting (AGM) for Changmao Biochemical Engineering Company Limited. It includes details about the date, time, location, agenda items such as approval of audited financial statements, re-appointment of auditors, granting a general mandate to issue new shares, and amendments to the Articles of Association. The document is clearly a meeting notice rather than the actual annual report or financial statements. It is a formal announcement inviting shareholders to attend the AGM and vote on various resolutions. Therefore, it fits the category of AGM Information (AGM-R). The document length and content confirm it is not a brief announcement or a proxy solicitation but a full AGM notice with detailed agenda.
2026-04-21 English
Proxy Form for annual general meeting to be held on 28 May 2026
AGM Information Classification · 100% confidence The document is a proxy form for the Annual General Meeting (AGM) of Changmao Biochemical Engineering Company Limited scheduled for 28 May 2026. It includes instructions for shareholders to appoint proxies to vote on resolutions at the AGM, including approval of audited financial statements, re-appointment of auditors, granting mandates to the board, and amendments to the Articles of Association. The content is clearly related to the AGM process and voting, not the actual annual report or financial statements themselves. Therefore, this document fits the category of AGM Information (AGM-R). The document length is 6451 characters, which is consistent with a detailed proxy form rather than a brief announcement or a full report.
2026-04-21 English
GENERAL MANDATE TO ISSUE NEW SHARES AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is a circular from Changmao Biochemical Engineering Company Limited dated April 21, 2026. It includes a notice of the Annual General Meeting (AGM) scheduled for May 28, 2026, details about a general mandate to issue new shares, proposed amendments to the Articles of Association, and a proxy form for the AGM. The content focuses on providing information to shareholders about the upcoming AGM, resolutions to be proposed, and procedural details for voting and attendance. There are no financial statements, audit reports, earnings data, or transcripts of calls. The document is not a report itself but a detailed circular related to the AGM, including the notice and explanatory materials. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM. The length and detail confirm it is not a mere announcement but a full circular for the AGM. Therefore, the appropriate classification is AGM-R with high confidence.
2026-04-21 English
ANNUAL REPORT 2025
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2025' for Changmao Biochemical Engineering Company Limited. It contains detailed sections typical of an annual report, including corporate profile, chairman's statement, management discussion and analysis, corporate governance report, environmental and social report, report of the directors, independent auditor's report, consolidated financial statements, and notes to the financial statements. The document length is 15,000 characters, indicating a comprehensive report rather than a brief announcement. The presence of audited consolidated financial statements and detailed business review confirms this is the full annual report for the fiscal year ended 31 December 2025. Therefore, the appropriate classification is Annual Report (10-K). FY 2025
2026-04-21 English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The document is an announcement from the Board of Changmao Biochemical Engineering Company Limited regarding proposed amendments to the Articles of Association. It mentions that a special resolution will be proposed at the upcoming Annual General Meeting (AGM) for shareholder approval. The document does not contain financial statements or detailed financial data, nor is it a full report. It is a formal announcement about governance changes and the upcoming AGM agenda item. The document length is 3830 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this fits best under the category of Governance Information (CGR), as it details proposed changes to the company's internal rules and governance documents (Articles of Association).
2026-04-21 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.